Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

I don't quite understand this:
"Not sure why anyone would be surprised or ask about this, IPIX even did data lock announcements on its recent trials"

From your earlier post:
"Keep in mind the process, and note that IPIX involvement is at the very end. It is in the dark until then, aside from anecdotal word or a planned interim peek.
1. CRO finishes the trial
2. CRO completes the raw data
3. CRO cleans the raw data, making it analyzable
4. CRO locks the analyzable data
5. CRO merges the treatment code file with the analyzable data (ie, matches up who got placebo and who got drug). This step is the "unblinding."
6. CRO gives the unblinded data to IPIX
7. IPIX analyzes the data
8. IPIX releases top line results
9. IPIX releases follow-up results as its analysis continues"

Your email from the CEO seems to indicate that they are at step 4.
"The anticipated sequence of news will be a) Data Lock, and b) thereafter, top-line results"
"The trial will be unblinded shortly."

It seems silly to parse that any further. Or is it? We've been provided the sequence, but if the secondary outcome and questionnaire issues are as tricky as we've been told then "thereafter" may not be that soon after "shortly".